Key Takeaways
- RKLB shares reached an unprecedented peak of $133.18, climbing 25.7% over seven trading days
- First-quarter 2026 revenue totaled $200.4 million, surpassing Wall Street’s $189.7 million projection
- Backlog surged to an unprecedented $2.2 billion, representing more than double the previous year’s figure
- Deutsche Bank lifted its target price by 64% to $120; Clear Street launched coverage with a $150 target
- The stock currently commands approximately 108x price-to-sales, significantly exceeding its historical 14.6x average
May started off uneventfully for Rocket Lab (RKLB) shareholders. That changed dramatically when first-quarter results emerged.
Following its May 7 after-hours earnings release for the first quarter of 2026, investor enthusiasm propelled the stock forward. By May 14, RKLB touched an unprecedented $133.18, representing a substantial 25.7% climb from the previous Friday’s closing price.
The aerospace company delivered quarterly revenue of $200.4 million—setting a new benchmark—exceeding Street expectations by over $10 million. This figure represents a robust 63.5% increase compared to the same period last year.
Gross profit margin reached 38.2% during Q1, establishing another company milestone. Meanwhile, the contracted work pipeline has expanded to $2.2 billion, more than doubling from twelve months prior.
Wall Street Raises Its Sights
Deutsche Bank maintained its bullish stance while boosting its price objective by 64%—jumping from $73 to $120—this Tuesday. This adjustment reflects growing conviction that RKLB’s expansion trajectory remains intact.
The following day, Clear Street launched coverage with a buy recommendation and established a $150 price objective, positioning among the Street’s most optimistic outlooks.
These represent substantial revisions rather than minor adjustments. Notably, both targets emerged after the stock reached its all-time peak, indicating analysts perceive continued upside potential despite elevated valuations.
Revenue Mix Evolution Continues
The company’s Space Systems segment has now eclipsed Launch Services as the dominant revenue contributor. This transition underscores Rocket Lab’s strategic evolution toward comprehensive vertical integration beyond pure launch capabilities.
Government and defense contract wins have contributed meaningfully. The $2.2 billion backlog incorporates substantial defense-related agreements, offering enhanced revenue visibility and stability.
Looking ahead to Q2 2026, management projected revenue between $225 million and $240 million, with anticipated gross margins ranging from 33% to 35%.
This outlook suggests ongoing sequential expansion, though profitability metrics may compress modestly from Q1’s exceptional 38.2% gross margin performance.
The Neutron launch system—Rocket Lab’s heavy-lift vehicle designed for commercial and institutional customers—nears its first commercial deployment. Market participants view this program as a potentially transformative long-term revenue catalyst.
Valuation metrics continue generating discussion. Trading around 108x trailing sales, RKLB commands a significant premium versus its five-year historical average of 14.6x.
This elevated multiple incorporates substantial growth assumptions, simultaneously creating vulnerability should operational performance or forward guidance fall short of expectations.
Nevertheless, with the backlog at unprecedented levels and analyst price objectives positioned above current trading levels, the technical and fundamental setup has maintained buying interest.
Rocket Lab shares settled at $126.94 on May 15, retreating modestly from the record peak while preserving most of the week’s substantial gains.


